Richard Pittner

Experience

1. Co-founder, Partner and Scientific Advisor-discovery

   Bioshore Partners

   Dec 2014 — Present · San Diego, CA, US

   BioShore Partners assembles drug development opportunities that leverage combinations of clinically validated bio-molecules and small molecule agents to treat an array of metabolic indications with unmet clinical needs. Leveraging its’ close connections to prominent researchers in academia and key opinion leaders in their respective fields, BioShore Partners provides a rich source of enabling technologies and access to world-class centers to conduct pre-clinical and clinical investigations to incubate and foster product concepts into new Biotech entities. Abvance Inc, a newly incorporated entity in 2016: In collaboration with a Diabetes KOL, developed intellectual property and supporting data for a novel treatment paradigm for T1DM and insulin-requiring T2DM patients, involving dual peptides in a fixed ratio - producing a simplified bionic pancreas treatment approach. Abvance Inc will be supported by BioShore team members. Aquoros Bio Inc, a newly incorporated entity in 2016: In collaboration with a thought leading urologist, developed intellectual property for a novel treatment paradigm for Interstitial Cystitis/Painful Bladder Syndrome (novel multi-drug treatment and delivery). Aquros Bio will be led by BioShore team members.

Education

• University of Nottingham

  Ph.D, Biochemistry

  1982 — 1985